Company Filing History:
Years Active: 2015
Title: Innovations by Chien-Hsi Chang in Breast Cancer Research
Introduction
Chien-Hsi Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in understanding the mechanisms of breast cancer. His work focuses on the interaction between nicotine-derived compounds and estrogen receptors, which has implications for cancer treatment.
Latest Patents
Chien-Hsi Chang holds a patent titled "Method of identifying a candidate compound which may inhibit α9-nAChR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells." This invention relates to methods for identifying compounds that can inhibit the proliferation of breast cancer cells influenced by nicotine. The patent highlights the discovery that α9-nAChR has an activating protein 1 (AP1)-binding site, which is crucial for understanding how estrogen receptors interact with this promoter.
Career Highlights
Chien-Hsi Chang is affiliated with Taipei Medical University, where he conducts research and contributes to advancements in cancer treatment. His innovative approach to identifying candidate compounds showcases his commitment to improving therapeutic strategies for breast cancer patients.
Collaborations
Chien-Hsi Chang has collaborated with notable colleagues, including Chia-Hwa Lee and Ya-Chieh Chang. Their joint efforts in research have furthered the understanding of cancer biology and potential treatment pathways.
Conclusion
Chien-Hsi Chang's work exemplifies the intersection of innovation and medical research, particularly in the fight against breast cancer. His contributions through patents and collaborations highlight the importance of continued research in this critical area.